103 related articles for article (PubMed ID: 28712392)
1. [Protection of Rho-associated protein kinase inhibitor Y-27632 in MRL/lpr mice].
Wang Y; Jia X; Wang Q; Ye M; Lu Y; Zhang J; Chen S; Li Y; Wu J; Xie C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):875-880. PubMed ID: 28712392
[TBL] [Abstract][Full Text] [Related]
2. Y-27632, a Rho-associated protein kinase inhibitor, inhibits systemic lupus erythematosus.
Wang Y; Lu Y; Chai J; Sun M; Hu X; He W; Ge M; Xie C
Biomed Pharmacother; 2017 Apr; 88():359-366. PubMed ID: 28122300
[TBL] [Abstract][Full Text] [Related]
3. [Effects of dexamethasone on MRL/lpr mice with systemic lupus erythematosus complicated with cognitive dysfunction].
Wang Y; Tang J; Shen L; Li J; Zha C; Wang R; Hu K; Xi J; Chang J; Xie C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):251-256. PubMed ID: 28364096
[TBL] [Abstract][Full Text] [Related]
4. [Glycyrrhizinic acid modulates the immunity of MRL/lpr mice and related mechanism].
Wang Y; Chai J; Sun M; He W; Hu X; Zou W; Li H; Lu Y; Xie C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):305-309. PubMed ID: 28274306
[TBL] [Abstract][Full Text] [Related]
5. [The Study of Protective Effect of Paeoniflorin on Lung Injury in MRL/lpr Mice].
Xie CH; Li ZJ; Chen LJ; Zhao P; Zhang JJ; Bai SW; Shen T; He WX; Wang YY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):394-398. PubMed ID: 30014641
[TBL] [Abstract][Full Text] [Related]
6. Paeoniflorin inhibits activation of the IRAK1-NF-κB signaling pathway in peritoneal macrophages from lupus-prone MRL/lpr mice.
Ji L; Hou X; Liu W; Deng X; Jiang Z; Huang K; Li R
Microb Pathog; 2018 Nov; 124():223-229. PubMed ID: 30149133
[TBL] [Abstract][Full Text] [Related]
7. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
Li X; Liu J; Zhao Y; Xu N; Lv E; Ci C; Li X
BMC Nephrol; 2022 Jul; 23(1):243. PubMed ID: 35804318
[TBL] [Abstract][Full Text] [Related]
8. p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice.
Iwata Y; Wada T; Furuichi K; Sakai N; Matsushima K; Yokoyama H; Kobayashi K
J Am Soc Nephrol; 2003 Jan; 14(1):57-67. PubMed ID: 12506138
[TBL] [Abstract][Full Text] [Related]
9. [Paeoniflorin ameliorates liver injury of MRL/lpr mice through inhibition of NF-κB pathway].
Xie C; Wu B; Xi J; Wang R; Zhang C; Li Y; Bai S; Zhang J; Shen T; Tang X; Wang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1467-1471. PubMed ID: 29268848
[TBL] [Abstract][Full Text] [Related]
10. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
[TBL] [Abstract][Full Text] [Related]
11. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
12. Paeoniflorin attenuates depressive behaviors in systemic lupus erythematosus mice.
Wang S; Zhao X; Qiao Z; Jia X; Qi Y
Biomed Pharmacother; 2018 Jul; 103():248-252. PubMed ID: 29655166
[TBL] [Abstract][Full Text] [Related]
13. [Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice].
Wang ZH; Zhang W; Zhang YQ; Pang CY; Wang YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):771-776. PubMed ID: 27752154
[TBL] [Abstract][Full Text] [Related]
14. Regulatory effect of IL-38 on NF-κB pathway in systemic lupus erythematosus.
Zhang J; Tabush N; Wei C; Luo L
Immunobiology; 2023 Mar; 228(2):152322. PubMed ID: 36621308
[TBL] [Abstract][Full Text] [Related]
15. STING upregulation mediates ferroptosis and inflammatory response in lupus nephritis by upregulating
Chen J; Chen P; Song Y; Wei J; Wu F; Sun J; Xu Z
J Biosci; 2024; 49():. PubMed ID: 38186000
[TBL] [Abstract][Full Text] [Related]
16. The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus.
Jin N; Wang Q; Zhang X; Jiang D; Cheng H; Zhu K
Int Immunopharmacol; 2011 Sep; 11(9):1319-26. PubMed ID: 21549858
[TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
You Y; Qin Y; Lin X; Yang F; Li J; Sooranna SR; Pinhu L
BMC Nephrol; 2015 Aug; 16():148. PubMed ID: 26310926
[TBL] [Abstract][Full Text] [Related]
18. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Rho-kinase in tumor necrosis factor-alpha-induced interleukin-6 release from C6 glioma cells.
Yamaguchi S; Tanabe K; Takai S; Matsushima-Nishiwaki R; Adachi S; Iida H; Kozawa O; Dohi S
Neurochem Int; 2009 Nov; 55(6):438-45. PubMed ID: 19427347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
